Covaxin Was Not A Fluke, Says Bharat Biotech Md, Health News, ET HealthWorld

Covaxin was not a fluke, says Bharat Biotech MD

Madurai: India’s first indigenous vaccine was not a fluke, but systematic efforts of around 3,000 people working at Bharat Biotech, said Suchitra Ella, managing director of Bharat Biotech and chairperson of Confederation of Indian Industries(CII) southern regin, while delivering a guest lecture at Thiagarajar college of engineering here on Thursday.

Speaking about the research in India, Ella said, “Indians are good at theory and academics but transforming the research into a commercial content or deploying it as a vaccine is challenging.” Ela was delivering a lecture to the students about the success journey of Covaxin and building entrepreneurial skills in students.

“As many as 27 billion children are born every year in India and every child takes 10 vaccines, we can’t rely on foreign nations for every vaccine and it is our duty to manufacture cost effective alternate vaccines,” Ella said, driving home the need to develop indigenous vaccines to meet the needs of India.

Elaborating on the success story of covaxin, the managing director said, “As there was a high pressure to manufacture an indigenous vaccine within a time limit, we produced the first covaxin in 30 days in an extremely challenging environment.” Around 27,500 volunteers came forward for clinical trials and the vaccine proved to pass all international vaccine regulations, said Ella.

She added that every student should have an entrepreneurial mindset apart from building skills and academic record. Students should try to be a problem solver and develop a long term vision as an entrepreneur which can be an asset to the society, said Ella. Around 150 students attended the guest lecture at the college.

Source link